The Center is focused on integrating AI into education, research, and clinical settings to enhance the diagnosis of various eye diseases.

The funding will be utilized to recruit a new Center director and an AI scientist, support research initiatives, and establish a clinical fellowship program in ophthalmic AI.

Mount Sinai's Icahn School of Medicine has received a transformative $5 million donation from the John and Daria Barry Foundation to support the newly established Center for Ophthalmic Artificial Intelligence and Human Health.

Following this generous contribution, the Center will be officially named The Barry Family Center for Ophthalmic Artificial Intelligence and Human Health.

In collaboration with the Windreich Department of Artificial Intelligence and Human Health, the Center aims to drive clinical innovation in AI-based ophthalmology diagnostics.

This financial support will enhance clinical programs aimed at equitable vision care and advance research for the early diagnosis of eye diseases.

Current research efforts will target conditions such as macular degeneration, diabetic retinopathy, and glaucoma, with the goal of preventing vision loss and associated cardiovascular risks.

The Center's innovative programs include tele-retina services and tele-consultations designed for timely diagnosis of eye emergencies.

Researchers at the Center are developing AI algorithms to analyze data, aiming to create unique ocular biomarkers and improve disease monitoring.

Daria Barry highlighted the critical need for better funding in glaucoma research, emphasizing the family's commitment to enhancing diagnoses and treatments.

James C. Tsai, MD, expressed gratitude for the donation, noting its significant role in advancing vision care standards at Mount Sinai.

Mount Sinai Health System is recognized as a leading academic medical institution in New York, dedicated to addressing complex health challenges through innovative care and research.